“Psychedelics, used responsibly and with proper caution, would be for psychiatry what the microscope is for biology or the telescope is for astronomy.”
— Stanislav Grof, M.D.
We believe psychedelic science can help drive social and systematic change as part of a transformational approach to managing mental health care. We want to empower people to begin to heal themselves and see a future where these medicines can be used alongside other modalities to support mental health and addiction recovery.
Nikean Foundation devotes its resources to programs that advance psychedelic science in hopes that we can build better tools for mental health care. We commit to working with open science partners to promote research and education in support of the beneficial use of psychedelics.
As members of a global society, we are facing unprecedented changes and challenges, many of which can feel overwhelming. This year’s International Forum on Consciousness will examine connections with self, others and nature that reach our inner desires to be part of an interconnected world. Perhaps transforming from an independent to a more interdependent sense of the individual, community, and society.
The New York Academy of Sciences host an evening on May 25th for Psychedelics for the Treatment of Depression & Psychiatric Disorders. To be moderated by Yale School of Medicine's Dr. John Krystal and features John E. Nichols of the Heffter Research Institute, Rachel Yehuda of Icahn School of Medicine at Mt. Sinai, and Roland Griffiths of Johns Hopkins University School of Medicine.
The name Nikean can be translated into “citizen of the city of victory.” It originates from the name of founder Sanjay Singhal’s biggest entrepreneurial failure 25 years ago — now he is taking the opportunity to transform that failure into success. The inspiration for the Foundation draws from personal struggles with family members suffering from mental health disorders and a search for better healing tools.